AHMEDABAD, 17 APRIL: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

HSBC on Indigo: Maintain Buy on Company, raise target price at Rs 5975 (Positive)

HSBC on Indian Hotels: Maintain Buy on Company, raise target price at Rs 944 (Positive)

Nuvama on Ajax Eng: Maintain Buy on Company, maintain target price at Rs 800 (Positive)

HSBC on Travel & Leisure: The travel & hotel sector continues to enjoy exceptionally strong trading, Q4 well supported by the Maha Kumbh & tight supply (Positive)

Bernstein on Telecom: Telecom stocks have remained the most defensive sector in an otherwise volatile mkt, Indian telecom companies leading gains across Asia. (Positive)

CLSA on Consumer: On PE, Indian FMCG stocks are among most expensive in world, especially in context of anaemic growth & shrinking returns (Neutral)

Nomura on Pharma: District court of Delaware rules that ‘780 patent covering Mirabegron is not invalid on grounds of enablement. Lupin & Zydus are currently selling Mirabegron generics (Neutral)

Nomura on Wipro: Maintain Buy on Company, cut target price at Rs 280 from Rs 340 (Neutral)

MS on Wipro: Maintain Underweight on Company, target price at Rs 265 (Neutral)

MS on Vedanta Fashion: Maintain Equal weight on Company, cut target price at Rs 850 (Neutral)

MS on ABFRL: Maintain Equal weight on Company, target price at Rs 269 (Neutral)

BofA on Wipro: Maintain Underperform on Company, cut target price at Rs 225 from Rs 260 (Negative)

Bernstein on Wipro: Maintain Underperform on Company, cut target price at Rs 200 (Negative)

Citi on Wipro: Maintain Sell on Company, cut target price at Rs 215 from Rs 240 (Negative)

HSBC on Spice Jet: Maintain Reduce on Company, target price at Rs 25.1 (Negative)

CLSA on Godrej CP: Downgrade to Underperform on Company, target price at Rs 1060 (Negative)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)